According to a recent LinkedIn post from Phantom Neuro, Founder and CEO Connor Glass is scheduled to participate in a panel titled “Entrepreneurship for Human Flourishing” at the Entrepreneurship Summit 2026, organized by the Harvard Business School Entrepreneurship Club. The event is set for March 29 at 2:30 PM ET and will feature founders working on technologies aimed at major global challenges, including Phantom Neuro’s minimally invasive muscle‑machine interface efforts.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights Glass alongside panelists from AgBiome and Vie Science, positioning Phantom Neuro within a group of venture‑backed innovators at the intersection of health, science, and technology. This type of visibility at a prominent academic and entrepreneurial forum may help reinforce Phantom Neuro’s brand in the neurotechnology and human‑machine interface segments, potentially aiding future fundraising, talent recruitment, and partnership development.
By emphasizing its focus on restoring and expanding human capability, Phantom Neuro is presented as operating in a high‑impact niche that aligns with broader trends in assistive and augmentation technologies. For investors, this public association with Harvard Business School’s entrepreneurship network could signal growing recognition within the innovation ecosystem, even though the post does not provide new details on product milestones, commercial traction, or financial performance.